Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study

Merikle E, Presnall C, Feaster T, Moxon R, Siemers E, Kerwin D, Cline S.

Trials. 2026 Mar 23;27(1):339. doi: 10.1186/s13063-026-09656-w.

From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management

Botchway BOA, Kousiappa I, Koupparis A, Papacostas S, Georgiades S, Bashiardes S, Hadjisavvas A, Loucaides G, Adamou A, Christou Y, Panayiotidis MI, Jovanovic A, Nicolaou N.

J Alzheimers Dis. 2026 May;111(1):5-31. doi: 10.1177/13872877261428636. Epub 2026 Mar 13.

Long-term exposure to ambient particulate matter and its association with Alzheimer's disease: influencing factors and a systematic review with meta-analysis

Zhao N, Chen Z, Sun H.

Front Public Health. 2026 Feb 4;14:1757872. doi: 10.3389/fpubh.2026.1757872. eCollection 2026.

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial

Duehring JA, Jacobs DM, Salmon DP, MacKelfresh AJ, Revta C, Meyer A, Schaeffer M, Schell-Mader S, Wassmann T, Wenzkowski C, Feldman HH, Edland SD; ADCS VIVA-MIND Study Group.

J Prev Alzheimers Dis. 2026 May;13(5):100531. doi: 10.1016/j.tjpad.2026.100531. Epub 2026 Mar 13.

Comparing Functional Consequences of Human iPSC-Microglia and Neural Stem Cell-Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease

Krattli RP Jr, Markarian M, Madan S, Swami D, McQuade A, Baulch JE, Blurton-Jones M, Acharya MM.

Aging Cell. 2026 Jan;25(1):e70341. doi: 10.1111/acel.70341.

Integrating noise as a risk factor in studies of Alzheimer's disease and dementia: Guidance for epidemiologic research

Bozigar M, Weuve J, Clark SN, Grady ST, Cantuaria ML, Cai YS, Roscoe C, Röösli M, Peters JL, Seto E, Vienneau D, Sørensen M, Neitzel RL, Hastings AL, Luben TJ, Andersen ZJ, Clark C, Hansell AL, Hystad P, Brauer M, Adar SD.

Alzheimers Dement. 2026 May;22(5):e71513. doi: 10.1002/alz.71513.

Evidence integration of acupuncture for prevention and treatment of Alzheimer's disease and mild cognitive impairment from a neuroimaging perspective

Zhu W, Li H, Wang K, Sun M, Xiang K, Shan S, Ke C.

J Alzheimers Dis. 2026 Apr;110(3):1038-1056. doi: 10.1177/13872877261420235. Epub 2026 Mar 20.

Longitudinal Multi-Domain Cognitive Assessment of Anti-Amyloid Monoclonal Antibodies Versus Acetylcholinesterase Inhibitors in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis

Lee CY, Hsu TW, Kao YC, Tseng PT, Hsu CW, Lin YH, Liang CS.

Geriatr Gerontol Int. 2026 Apr;26(4):e70492. doi: 10.1111/ggi.70492.

Loneliness as an Interface Between Alzheimer's Disease and Suicidal Behaviour: A Systematic Review, Meta-Analysis and Meta-Analytic Factor Analysis

Rodrigues JFR, Rodrigues LP, Teshima T, Yang S, Wu Y, Hu X, Abarca GIF, da Cruz KCT, Rodriguez MFS, Rubatino FVM, Yamakawa M, de Godoy MF, Filho GMA.

Psychogeriatrics. 2026 May;26(3):e70165. doi: 10.1111/psyg.70165.

Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial

Juni JE, Burns JM, Salat DH, Hill D, Tally S, Martin JS, Devous MD, Moriarty PM.

Am J Alzheimers Dis Other Demen. 2026 Jan-Dec;41:15333175261451918. doi: 10.1177/15333175261451918. Epub 2026 May 14.

Characteristics of infusion-related reactions to lecanemab in early Alzheimer's disease: A multicenter real-world study in Northwestern China

Liu P, Liu J, Wang J, Du Y, Liu Z, Zhang H, Zhu A, Zhang G, Meng X, Zhao C, Zhang W, Dang L, Zhang W, Qu Q, Qu Y.

J Prev Alzheimers Dis. 2026 May;13(5):100542. doi: 10.1016/j.tjpad.2026.100542. Epub 2026 Mar 19.

[BIN1 (amphiphysin 2) in the pathogenesis of cognitive impairment]

Shamakina IY, Kokhan VS, Venkova VA, Baronets VY, Popov SS, Anokhin PK.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(3):45-52. doi: 10.17116/jnevro202612603145.

Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer's disease

Jain S, Tunc EB, Grossberg GT.

Expert Opin Pharmacother. 2026 Apr;27(6):531-544. doi: 10.1080/14656566.2026.2662949. Epub 2026 Apr 21.

Urinary tract infection-related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities

Kim S, Kremen S, Danovitch I, Lahiri S.

Alzheimers Dement. 2026 Feb;22(2):e71184. doi: 10.1002/alz.71184.

Angiogenic and anti-angiogenic factors are the shared mechanistic pathways between preeclampsia and Alzheimer's disease: Perspective and take-away

Abbas AM, Al-Kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Alharbi W, Fawzy MN, Batiha GE.

Vascul Pharmacol. 2026 Mar;162:107583. doi: 10.1016/j.vph.2026.107583. Epub 2026 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias